131 related articles for article (PubMed ID: 12763216)
1. Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965).
Dziadziuszko R; Ardizzoni A; Postmus PE; Smit EF; Price A; Debruyne C; Legrand C; Giaccone G;
Eur J Cancer; 2003 Jun; 39(9):1271-6. PubMed ID: 12763216
[TBL] [Abstract][Full Text] [Related]
2. A phase II trial of temozolomide for patients with recurrent or progressive brain metastases.
Abrey LE; Olson JD; Raizer JJ; Mack M; Rodavitch A; Boutros DY; Malkin MG
J Neurooncol; 2001 Jul; 53(3):259-65. PubMed ID: 11718258
[TBL] [Abstract][Full Text] [Related]
3. Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: phase II study.
Giorgio CG; Giuffrida D; Pappalardo A; Russo A; Santini D; Salice P; Blanco G; Castorina S; Failla G; Bordonaro R
Lung Cancer; 2005 Nov; 50(2):247-54. PubMed ID: 16039010
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors.
Kouvaris JR; Miliadou A; Kouloulias VE; Kolokouris D; Balafouta MJ; Papacharalampous XN; Vlahos LJ
Onkologie; 2007 Jul; 30(7):361-6. PubMed ID: 17596744
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: a GLOT-GFPC study.
Cortot AB; Gerinière L; Robinet G; Breton JL; Corre R; Falchero L; Berard H; Gimenez C; Chavaillon JM; Perol M; Bombaron P; Mercier C; Souquet PJ; ;
Ann Oncol; 2006 Sep; 17(9):1412-7. PubMed ID: 16790516
[TBL] [Abstract][Full Text] [Related]
6. Phase II Study of the Efficacy and Safety of High-dose Pemetrexed in Combination with Cisplatin
He Q; Bi X; Ren C; Wang Y; Zou P; Zhang H; Chi N; Xiu C; Wang Y; Tao R
Anticancer Res; 2017 Aug; 37(8):4711-4716. PubMed ID: 28739776
[TBL] [Abstract][Full Text] [Related]
7. Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study.
Siena S; Crinò L; Danova M; Del Prete S; Cascinu S; Salvagni S; Schiavetto I; Vitali M; Bajetta E
Ann Oncol; 2010 Mar; 21(3):655-661. PubMed ID: 19767314
[TBL] [Abstract][Full Text] [Related]
8. Whole-brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small-cell lung cancer: a randomized, open-label phase II study.
Chua D; Krzakowski M; Chouaid C; Pallotta MG; Martinez JI; Gottfried M; Curran W; Throuvalas N
Clin Lung Cancer; 2010 May; 11(3):176-81. PubMed ID: 20439193
[TBL] [Abstract][Full Text] [Related]
9. Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer.
Ebert BL; Niemierko E; Shaffer K; Salgia R
Oncologist; 2003; 8(1):69-75. PubMed ID: 12604733
[TBL] [Abstract][Full Text] [Related]
10. Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study.
Agarwala SS; Kirkwood JM; Gore M; Dreno B; Thatcher N; Czarnetski B; Atkins M; Buzaid A; Skarlos D; Rankin EM
J Clin Oncol; 2004 Jun; 22(11):2101-7. PubMed ID: 15169796
[TBL] [Abstract][Full Text] [Related]
11. Temozolomide added to whole brain radiotherapy in patients with multiple brain metastases of non-small-cell lung cancer: a multicentric Austrian phase II study.
Hassler MR; Pfeifer W; Knocke-Abulesz TH; Geissler K; Altorjai G; Dieckmann K; Marosi C
Wien Klin Wochenschr; 2013 Aug; 125(15-16):481-6. PubMed ID: 23907204
[TBL] [Abstract][Full Text] [Related]
12. Whole brain reirradiation and concurrent temozolomide in patients with brain metastases.
Minniti G; Scaringi C; Lanzetta G; Bozzao A; Romano A; De Sanctis V; Valeriani M; Osti M; Enrici RM
J Neurooncol; 2014 Jun; 118(2):329-334. PubMed ID: 24718862
[TBL] [Abstract][Full Text] [Related]
13. Strategies to prevent brain metastasis in high-risk non-small-cell lung cancer: lessons learned from a randomized study of maintenance temozolomide versus observation.
Boggs DH; Robins HI; Langer CJ; Traynor AM; Berkowitz MJ; Mehta MP
Clin Lung Cancer; 2014 Nov; 15(6):433-40. PubMed ID: 25069747
[TBL] [Abstract][Full Text] [Related]
14. Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases.
Addeo R; De Rosa C; Faiola V; Leo L; Cennamo G; Montella L; Guarrasi R; Vincenzi B; Caraglia M; Del Prete S
Cancer; 2008 Nov; 113(9):2524-31. PubMed ID: 18798231
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of temozolomide for leptomeningeal metastases in patients with solid tumors.
Segura PP; Gil M; Balañá C; Chacón I; Langa JM; Martín M; Bruna J
J Neurooncol; 2012 Aug; 109(1):137-42. PubMed ID: 22610937
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker.
Pietanza MC; Kadota K; Huberman K; Sima CS; Fiore JJ; Sumner DK; Travis WD; Heguy A; Ginsberg MS; Holodny AI; Chan TA; Rizvi NA; Azzoli CG; Riely GJ; Kris MG; Krug LM
Clin Cancer Res; 2012 Feb; 18(4):1138-45. PubMed ID: 22228633
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
Deng X; Zheng Z; Lin B; Su H; Chen H; Fei S; Fei Z; Zhao L; Jin X; Xie CY
BMC Cancer; 2017 Jan; 17(1):42. PubMed ID: 28068937
[TBL] [Abstract][Full Text] [Related]
18. Radiochemotherapy for brain metastasis: how to define a role for temozolomide.
Weller M
Onkologie; 2007 Jul; 30(7):350-1. PubMed ID: 17596741
[No Abstract] [Full Text] [Related]
19. A phase II EORTC study of temozolomide in patients with malignant pleural mesothelioma.
van Meerbeeck JP; Baas P; Debruyne C; Smit EF; van Klaveren RJ; Galdermans D; Lentz MA; Manegold C; Giaccone G;
Eur J Cancer; 2002 Apr; 38(6):779-83. PubMed ID: 11937311
[TBL] [Abstract][Full Text] [Related]
20. Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group.
Woll PJ; Judson I; Lee SM; Rodenhuis S; Nielsen OS; Buesa JM; Lorigan PC; Leyvraz S; Hermans C; van Glabbeke M; Verweij J
Eur J Cancer; 1999 Mar; 35(3):410-2. PubMed ID: 10448291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
